Non-U.S. sales
“10-K Item 1: 'Non-U.S. sales, as reflected in Part II Item 7. Results of Operations of this 2025 Form 10-K, accounted for approximately 93%, 93%, and 91% of total revenue'”
Updated
The most significant concentration Lam Research discloses is Non-U.S. sales at 93%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Lam Research’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1: 'Non-U.S. sales, as reflected in Part II Item 7. Results of Operations of this 2025 Form 10-K, accounted for approximately 93%, 93%, and 91% of total revenue'”
“10-K Item 1A: 'Certain components and sub-assemblies that we include in our products may only be obtained from a single supplier.'”
“10-K Item 1A: 'Sales to a limited number of large customers constitute a significant portion of our overall shipments, revenue, cash flows and profitability.'”
Lam Research's concentrations combine a heavy structural footing with supplier and customer dependencies. Non-U.S. sales accounted for approximately 93%, 93%, and 91% of total revenue across the years reported. That is a high-share geographic exposure and a stable one, so the company is tied to global trade policy, export rules, and foreign capital spending as a permanent feature of the model. On the supply side, certain components and sub-assemblies may only be obtained from a single supplier. This is a high-share dependency and the most idiosyncratic item here: a problem at one vendor could constrain output of the affected systems with no easy alternative. On the demand side, sales to a limited number of large customers constitute a significant portion of shipments, revenue, cash flows and profitability. This is a medium-share dependency; the filing gives no percentage, so the band is the only sizing guide. Large buyers can defer or cancel orders, which makes revenue lumpy. Netted out, geography is the constant backdrop, while single-source supply and customer ordering are the idiosyncratic risks most likely to move the verdict.
For the engine’s reasoning on LRCX’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ACLS | Axcelis Technologies, Inc. | 3 | 1 | 0 | 4 |
| ACMR | ACM Research, Inc. | 3 | 0 | 0 | 3 |
| AMBA | Ambarella, Inc. | 3 | 0 | 0 | 3 |
| AEHR | Aehr Test Systems | 2 | 1 | 0 | 3 |
| LRCX● | Lam Research Corporation | 2 | 1 | 0 | 3 |
| AMAT | Applied Materials, Inc. | 2 | 0 | 2 | 4 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.